EWJ vs IBB
iShares MSCI Japan ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.49% for EWJ.
- • EWJ pays a higher dividend yield (4.08%).
Side-by-side metrics
| Metric | EWJ | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.44% |
Dividend yield Trailing 12-month yield. | 4.08% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $20.98B | $7.95B |
YTD return | 13.55% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.80 | 0.74 |
P/E ratio | 18.38 | 23.72 |
Last price | $90.99 | $170.10 |
Inception | — | — |
Issuer | iShares | iShares |
EWJ top holdings
| 8306.T | Mitsubishi UFJ Financial Group Inc | 4.09% |
| 7203.T | Toyota Motor Corp | 3.72% |
| 6501.T | Hitachi Ltd | 2.92% |
| 6857.T | Advantest Corp | 2.87% |
| 8316.T | Sumitomo Mitsui Financial Group Inc | 2.61% |
| 8035.T | Tokyo Electron Ltd | 2.55% |
| 6758.T | Sony Group Corp | 2.51% |
| 9984.T | SoftBank Group Corp | 2.47% |
| 8411.T | Mizuho Financial Group Inc | 2.18% |
| 8058.T | Mitsubishi Corp | 2.00% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About EWJ
EWJ (iShares MSCI Japan ETF) is Japanese large- and mid-cap equities. Managed by iShares, the fund carries $21.0B in assets under management, an expense ratio of 0.49%, a dividend yield of 4.08%. Its largest holding is Mitsubishi UFJ Financial Group Inc (8306.T), which represents 4.1% of the portfolio. Real Estate is the fund's largest sector exposure at 2.3%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.